Nicholas Focil is the CEO at Fomat Medical Research, a network of research centers based in Oxnard, California. Nicholas graduated from California with a Biochemistry and MBA degree. During his undergrad days, he spent his extra time in a research lab working with a nominated noble laureate performing investigator-initiated studies, and publishing weekly articles for a spectrum of publications. Was then recruited by Medtronic MiniMed Diabetes division to do pre-pivotal trials. Thereafter, was recruited for the purpose of managing and expanding Diverse Research Solutions. He then spearheaded the spinoff and expansion of FORMAT Medical Research through both the U.S. and Latin America with current operations in the USA (California and Florida), Ecuador, Colombia, and Peru. With well over a decade of research experience, Nicholas, as the CEO of Fomat Medical Research and proud founding partner of hyper core International, continues to innovate and pioneer clinical research in both regions.
Nicholas Focil, CEO at Fomat Medical Research
Newsletter
Get the Global Trial Accelerators™ newsletter
Practical insights on first-in-human and early feasibility trials across medtech, biotech/biopharma and radiopharma, in your inbox.
Free. Unsubscribe anytime. See the bioaccess® Privacy Policy (opens in a new tab) and the newsletter platform's Terms of Service (opens in a new tab).
Recent Episodes
- Varun Kalaiarasan, PhD Researcher at University of Cincinnati
- Ryan Beal, Chief Executive Officer at Dyve Biosciences
- Sandi Schaible, Founder & President at Bonded in Science
- Gennaro Maida, CEO and Founder at Denovo Innovations Group
- Benjamin Holmes, Chief Executive Officer at Nanochon
- Allison Komiyama, CEO and Founder at Bluestocking Health, LLC
- Daniel Zequeto, Founder & CEO at ODC Life Sciences
- Satabhisa Mukhopadhyay, Founder & Chief Scientist at 4D Path Inc
- Deborah Morley, Director CV Strategy and Delivery at RQM+
- See all →